Danaher Co. (NYSE:DHR) Shares Sold by Stratos Wealth Advisors LLC

Stratos Wealth Advisors LLC lowered its holdings in Danaher Co. (NYSE:DHR) by 1.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 13,890 shares of the conglomerate’s stock after selling 184 shares during the quarter. Stratos Wealth Advisors LLC’s holdings in Danaher were worth $3,189,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in DHR. Fort Pitt Capital Group LLC grew its position in Danaher by 3.2% during the third quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after buying an additional 7,421 shares during the period. Good Life Advisors LLC purchased a new stake in shares of Danaher during the 3rd quarter worth approximately $217,000. ORG Partners LLC increased its stake in Danaher by 1,212.8% in the 4th quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after purchasing an additional 2,559 shares in the last quarter. Harvest Portfolios Group Inc. raised its holdings in Danaher by 1.2% during the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock worth $56,233,000 after purchasing an additional 2,465 shares during the last quarter. Finally, Stifel Financial Corp boosted its position in Danaher by 1.3% during the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock worth $235,583,000 after purchasing an additional 11,216 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on DHR shares. TD Cowen raised their price target on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Guggenheim initiated coverage on shares of Danaher in a research report on Thursday, December 19th. They set a “buy” rating and a $275.00 target price for the company. JPMorgan Chase & Co. lowered their price target on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. KeyCorp lifted their price objective on Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 23rd. Finally, Stifel Nicolaus increased their target price on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. Seven research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Insider Transactions at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 10.90% of the company’s stock.

Danaher Stock Down 1.4 %

Shares of DHR opened at $211.92 on Thursday. The firm has a market cap of $153.07 billion, a PE ratio of 40.14, a price-to-earnings-growth ratio of 2.80 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The company’s fifty day moving average is $234.50 and its two-hundred day moving average is $252.68. Danaher Co. has a fifty-two week low of $210.04 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter last year, the firm earned $2.09 earnings per share. Analysts forecast that Danaher Co. will post 7.77 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were paid a dividend of $0.27 per share. The ex-dividend date was Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.51%. Danaher’s dividend payout ratio is currently 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.